U.S. Health and Human Services Secretary Robert F. Kennedy, Jr. has renewed a 2017 public health emergency declaration regarding opioid abuse, giving the HHS flexibility to ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online ...

Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

Lawmakers are hoping to expand and improve upon a 2015 law that offers grants to county jails treating inmates experiencing ...

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people ...